Abstract
A synergistic effect between alpha-Interferon and Bleomycin has been recently shown in in vitro and in vivo experimental systems. Although active, Bleomycin and other antineoplastic drugs give low response rates in non-small cell lung cancer, but, like the other antineoplastic agents, responses are short-lived. We treated 13 patients with advanced non-small cell lung cancer with the combination Bleomycin 15 mg/m2 i.v. at hour 0 and alpha-Interferon 9 x 106 U i.m. given at hours 6, 30 and 54. Major side effects were pyrexia, astenia and anorexia; only one case of moderate leukopenia was observed. No major responses were obtained and stable disease lasted a median of 5 months. Further study of this combination is not warranted in patients with pretreated non-small cell lung cancer.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 405-408 |
| Numero di pagine | 4 |
| Rivista | Anticancer Research |
| Volume | 9 |
| Numero di pubblicazione | 2 |
| Stato di pubblicazione | Pubblicato - 1989 |
| Pubblicato esternamente | Sì |
OSS delle Nazioni Unite
Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile
